THERAPEUTIC MONOCLONAL ANTIBODIES MARKET

Therapeutic Monoclonal Antibodies Market

How will the market for monoclonal antibody (mAb) therapies perform from 2011? Visiongain's report shows you potential revenues to 2021. Find opportunities and prospects.

How will competition affect the mAb industry and market? Which national markets have the greatest potential for growth? You can find predictions and explanations in this study. It covers cancer, autoimmune diseases and other applications for therapeutic mAbs.

Discover mAb treatment revenues at total world, submarket, product and national levels. Through our research and analysis we aim to save you time and help in your decisions.

The monoclonal antibody drug market has potential to expand. See how treatments such as Avastin, Herceptin, MabThera, Remicade, Humira, Tysabri and Lucentis can perform to 2021. Find potential revenues.

Discover commercial prospects for Roche, J&J, Abbott, Biogen Idec, Novartis and other companies. Markets and R&D pipelines for mAb-based treatments remain strong.

Our report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Analysis with revenues, future growth rates, market shares, opinions and discussions

In our report you find revenue forecasts, growth rates, market shares, qualitative analyses (incl. SWOT), an R&D review and opinions from our survey. You receive 81 tables and charts and three research interviews (see the table of contents).

Therapeutic Monoclonal Antibodies: World Market 2011-2021 shows you opportunities, challenges and revenue forecasts

Our report gives you the following advantages in particular:
• Find revenue predictions to 2021 for the world monoclonal antibody drug market and submarkets, seeing revenue growth
• Discover revenue forecasts to 2021 for leading mAb treatments, assessing market potentials
• Assess leading companies, discovering their activities and outlooks

Read » Therapeutic Monoclonal Antibodies Market

Published 3 hours 55 min ago – Made popular 16 min 52 sec ago
Category: Business | Tags:

Login or register to post comments

Stories similar to Therapeutic Monoclonal Antibodies Market :

Additional information on Therapeutic Monoclonal Antibodies Market :
- May 1, 2012 ... Therapeutic monoclonal antibodies (mAbs) are currently being approved for marketing in Europe and the United States, as well as other ...
- Oct 10, 2012 ... The European market for therapeutic monoclonal antibody products will be worth $42.4bn by 2018 thanks to 11 per cent year-on-year growth, ...
- Since 2000, the therapeutic market for monoclonal antibodies has grown exponentially. The current “big 5” therapeutic antibodies on the market are ...
- May 8, 2012 ... Existing adoption rates and commercial success of launched monoclonal antibodies (MAbs) for therapeutics have established a strong platform ...
- Trends in Therapeutic Monoclonal Antibody Discovery Technology ... technology warrant careful consideration by market participants. The Tabs database [3] ...
- The global market for therapeutic monoclonal antibodies (mAbs) was estimated at $44.6 billion in 2011. With the rollout of at least eight new therapeutic mAb ...
- Oct 9, 2012 ... New analysis from Frost & Sullivan, Analysis of the Therapeutic Monoclonal Antibodies Market in Europe, (www.pharma.frost.com), finds that ...
- Mar 20, 2012 ... Global market for therapeutic monoclonal antibodies to grow to $58 billion in 2016. The global market fortherapeutic monoclonal antibodies ...

Related links about Therapeutic Monoclonal Antibodies Market :
1. Frost & Sullivan Predicts Growth for the Therapeutic Monoclonal ...
2. Monoclonal antibody therapy - Wikipedia, the free encyclopedia
3. BIO016H - Antibody Drugs: Technologies and Global Markets
4. Trends in Therapeutic Monoclonal Antibody Discovery Technology
5. Therapeutic monoclonal antibodies market - Is Biologics the answer ...

World Multiple Myeloma Drug Treatment Market 7 weeks 4 days ago

Bharat Book Bureau has announced the addition of the "World Multiple Myeloma Drug Treatment Market 2012-2022" report to their offering.

See what the future holds for products to treat multiple myeloma. Visiongain's updated report gives you revenue predictions to 2022. There you find data, trends, opportunities and commercial prospects.

Our study lets you assess forecasted sales at overall world market, product and national level. Those analyses help you see the future of that industry and market.

Cancer Monoclonal Antibodies Market 1 week 2 days ago

Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease more efficiently and with enhanced specificity, monoclonal antibodies have become the most widely used cancer therapy. As per the findings of our new research report, cancer monoclonal antibodies provide high specificity to treat tumors and several formats exist for the types of cancer monoclonal antibodies available.

Future of Monoclonal Antibodies - Market Forecasts to 2015 3 years 9 weeks ago

GBI Research, the leading business intelligence provider, has released its latest research “The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global monoclonal antibodies market. The report analyzes the markets for monoclonal antibodies in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan.

Global Monoclonal Antibody Market Analysis 2 years 11 weeks ago

Considered as an indispensable tool in the clinical and biotechnology sector, monoclonal antibodies have testified to be useful in the diagnosis and treatment of many infectious, immune, and neoplastic diseases along with its application in the study of pathogen-host interactions and dialing, detection, & quantification of different molecules.The presence of monoclonal antibodies therapeutics has changed the face of modern medicine in the past decade as they provide innovative and effective therapies for numerous previously refractory illnesses.

Biobanking for Medical R&D Market Report 3 hours 51 min ago

Do you want to know the prospects for biobanking in medical research, pharmaceutical R&D and personalised medicine? Our new study shows you its technological and commercial potential. You can have that report today, staying ahead. Demand for biobanking has been expanding. There will be commercial growth, with important trends to watch from 2010 onwards.